Concepedia

Eileen Z. Zhang

EZ

Statistics

Publications

8

Citations

680

H-Index

8

Active since

2008

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Janssen (Belgium)

Cornell University

Goethe University Frankfurt

Janssen (United States)

Eileen Z. Zhang is an author at Vertex Pharmaceuticals (United States) specializing in viral hepatitis, clinical studies, and hepatitis c.

Top concepts

Publications per year

2008–2014

8

Publications

8

Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3·4A Protease Inhibitors in Treatment‐Naive Subjects

Doug J. Bartels, Yi Zhou, Eileen Z. Zhang et al. · The Journal of Infectious Diseases · 2008 · 206 citations

Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials

James C. Sullivan, Sandra De Meyer, Doug J. Bartels et al. · Clinical Infectious Diseases · 2013 · 164 citations · Full text

Hepatitis C Virus Variants with Decreased Sensitivity to Direct-Acting Antivirals (DAAs) Were Rarely Observed in DAA-Naive Patients prior to Treatment

Doug J. Bartels, James C. Sullivan, Eileen Z. Zhang et al. · Journal of Virology · 2012 · 144 citations · Full text

Hepatitis C Viral Evolution in Genotype 1 Treatment-Naïve and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials

Tara L. Kieffer, Sandra De Meyer, Doug J. Bartels et al. · PLoS ONE · 2012 · 87 citations · Full text

Development of a sensitive RT-PCR method for amplifying and sequencing near full-length HCV genotype 1 RNA from patient samples

Eileen Z. Zhang, Doug J. Bartels, J. Daniel Frantz et al. · Virology Journal · 2013 · 24 citations · Full text

1–5 of 8